Cosmos Health (COSM) Retained Earnings (2011 - 2026)
Cosmos Health's (COSM) quarterly Retained Earnings came in at $164.1 million in Q2 2026, up 13.7% on a YoY basis from $144.3 million in Q2 2025, and up 4.77% quarter-over-quarter from $156.6 million in Q1 2026.
Analysis
Cosmos Health (COSM) Retained Earnings (2011 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Retained Earnings for 16 consecutive years, with $164.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings rose 13.7% year-over-year to $164.1 million; the trailing twelve-month figure through Jun 2026 stood at $164.1 million (up 13.7% YoY), and the FY2025 full-year result was $152.1 million, up 7.45% from the prior year.
- Retained Earnings improved to $164.1 million in Q2 2026 per COSM's latest filing, from $156.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $164.1 million in Q2 2026 and bottomed at $40.6 million in Q1 2022.
- Historically, Retained Earnings has averaged $121.9 million across 5 years, with a median of $130.1 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings soared 294.26% in 2022, then rose 3.93% in 2025.
- Over 5 years, Retained Earnings stood at $112.2 million in 2022, then increased by 14.97% to $129.0 million in 2023, then increased by 9.75% to $141.6 million in 2024, then advanced by 7.45% to $152.1 million in 2025, then climbed by 7.86% to $164.1 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $164.1 million, $156.6 million, and $152.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | -10.83 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -2.48 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 620.25 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | -227.25 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 164.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.10 Mn |
| Mar 31, 2026 | 156.63 Mn |
| Dec 31, 2025 | 152.14 Mn |
| Sep 30, 2025 | 146.33 Mn |
| Jun 30, 2025 | 144.33 Mn |
| Mar 31, 2025 | 142.79 Mn |
| Dec 31, 2024 | 141.58 Mn |
| Sep 30, 2024 | 140.80 Mn |
| Jun 30, 2024 | 130.32 Mn |
| Mar 31, 2024 | 129.98 Mn |
| Dec 31, 2023 | 129.01 Mn |
| Sep 30, 2023 | 117.79 Mn |
| Jun 30, 2023 | 112.86 Mn |
| Mar 31, 2023 | 112.30 Mn |
| Dec 31, 2022 | 112.21 Mn |
| Sep 30, 2022 | 61.19 Mn |
| Jun 30, 2022 | 59.86 Mn |
| Mar 31, 2022 | 40.65 Mn |
| Dec 31, 2021 | 39.69 Mn |
| Sep 30, 2021 | 30.15 Mn |